Arcutis Biotherapeutics Inc
NASDAQ:ARQT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Arcutis Biotherapeutics Inc
NASDAQ:ARQT
|
US |
|
Tokyo Metro Co Ltd
TSE:9023
|
JP |
|
W
|
WW Grainger Inc
XMUN:GWW
|
US |
|
A
|
Alpha Pro Tech Ltd
AMEX:APT
|
CA |
|
Tripadvisor Inc
NASDAQ:TRIP
|
US |
|
C
|
Comstock Inc
AMEX:LODE
|
US |
|
P
|
Puma SE
F:PUM
|
DE |
|
I
|
Icade SA
OTC:CDMGF
|
FR |
|
MatsukiyoCocokara & Co
OTC:MSMKF
|
JP |
Shareholder Yield
Current shareholder yield for ARQT is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
ARQT Price
Arcutis Biotherapeutics Inc
| Average Annual Return | 49.44% |
| Standard Deviation of Annual Returns | 185.17% |
| Max Drawdown | -94% |
| Market Capitalization | 2.6B USD |
| Shares Outstanding | 125 080 000 |
| Percentage of Shares Shorted | 14.96% |
